Oxford Global is proud to present Biomarkers 2023, uniting seniorlevel experts to provide a focussed forum for thought-provoking discussion and to gain insights from the key figures in the community. The comprehensive programme allows you to gain a forward-looking perspective on the latest technologies and strategies impacting biomarker research across multiple applications and therapeutic areas.
Benefits to Attending
Benefits to Attending
- Hear from and meet with the key industry and academic innovators in biomarkers, translational medicine, clinical development and diagnostics. 2023 attendees include: Vice Presidents from F-star, AstraZeneca, Crescendo Biologics and PsiOxus Therapeutics.
- Discover the latest integration of biomarkers in early drug development through case studies by major pharma on multiple therapeutic areas, including immuno-oncology, neuroscience, cardiology, immunology respiratory rare diseases, and cell and gene therapies.
- Gain novel insights into key biomarkers for detection, monitoring and diagnosis, including innovative applications of digital markers. Further talks look at early detection of cancer.
- Discuss the use of cellular, transcriptomic and proteomic biomarkers in preclinical and clinical development: trial design & data analysis, assay development, patient stratification & selection and the role of safety and efficacy markers.
- Benefit from case studies on topical technology innovation within digital pathalogy, AI & imaging, flow cytometry, multiplexing, mass spectrometry and spatial biology tools.
- Unparalleled networking opportunities. The two-day congress offers an interactive platform for high-level scientific and business discussions. Participate in formal or informal discussions during our networking breaks and pre-organised 1-2-1 meetings.
- Benefit from post-conference workshop focused day on 1st March covering Precision Oncology, Spatial Biology and Digital Biomarkers
